These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14989425)

  • 1. Is there a rationale for combined TNF and IL-1 blocking in arthritis?
    van den Berg WB
    Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S21-5. PubMed ID: 14989425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cytokine therapy in chronic destructive arthritis.
    van den Berg WB
    Arthritis Res; 2001; 3(1):18-26. PubMed ID: 11178124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
    Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
    J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arguments for interleukin 1 as a target in chronic arthritis.
    van den Berg WB
    Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i81-4. PubMed ID: 11053095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.
    Ross SE; Williams RO; Mason LJ; Mauri C; Marinova-Mutafchieva L; Malfait AM; Maini RN; Feldmann M
    J Immunol; 1997 Dec; 159(12):6253-9. PubMed ID: 9550429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
    Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
    J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis rats.
    Feige U; Hu YL; Gasser J; Campagnuolo G; Munyakazi L; Bolon B
    Cell Mol Life Sci; 2000 Sep; 57(10):1457-70. PubMed ID: 11078023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis.
    Koenders MI; Joosten LA; van den Berg WB
    Ann Rheum Dis; 2006 Nov; 65 Suppl 3(Suppl 3):iii29-33. PubMed ID: 17038468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice.
    Probert L; Plows D; Kontogeorgos G; Kollias G
    Eur J Immunol; 1995 Jun; 25(6):1794-7. PubMed ID: 7615010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of TNF-alpha and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-alpha/anti-CD4 therapy.
    Williams RO; Marinova-Mutafchieva L; Feldmann M; Maini RN
    J Immunol; 2000 Dec; 165(12):7240-5. PubMed ID: 11120857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-beta peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin-1.
    Sutton ET; Thomas T; Bryant MW; Landon CS; Newton CA; Rhodin JA
    J Submicrosc Cytol Pathol; 1999 Jul; 31(3):313-23. PubMed ID: 10626000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour necrosis factor activates the mitogen-activated protein kinases p38alpha and ERK in the synovial membrane in vivo.
    Görtz B; Hayer S; Tuerck B; Zwerina J; Smolen JS; Schett G
    Arthritis Res Ther; 2005; 7(5):R1140-7. PubMed ID: 16207331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A follow-up to "Anti-cytokine therapy in chronic destructive arthritis" by Wim B van den Berg.
    Brennan FM
    Arthritis Res; 2001; 3(4):211-3; discussion 214-5. PubMed ID: 11438037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of IL-1, IL-6, and TNF-alpha in immune-mediated inflammatory diseases.
    Möller B; Villiger PM
    Springer Semin Immunopathol; 2006 Jun; 27(4):391-408. PubMed ID: 16738952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody.
    Fischer JA; Hueber AJ; Wilson S; Galm M; Baum W; Kitson C; Auer J; Lorenz SH; Moelleken J; Bader M; Tissot AC; Tan SL; Seeber S; Schett G
    Arthritis Rheumatol; 2015 Jan; 67(1):51-62. PubMed ID: 25303306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis.
    Macías I; García-Pérez S; Ruiz-Tudela M; Medina F; Chozas N; Girón-González JA
    J Rheumatol; 2005 Nov; 32(11):2102-8. PubMed ID: 16265686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment.
    Ziolkowska M; Kurowska M; Radzikowska A; Luszczykiewicz G; Wiland P; Dziewczopolski W; Filipowicz-Sosnowska A; Pazdur J; Szechinski J; Kowalczewski J; Rell-Bakalarska M; Maslinski W
    Arthritis Rheum; 2002 Jul; 46(7):1744-53. PubMed ID: 12124857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
    Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB
    Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.